Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
Condition(s):Hematologic MalignancyLast Updated:March 22, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Hematologic MalignancyLast Updated:March 22, 2024Recruiting
Condition(s):HealthyLast Updated:August 25, 2022Completed
Condition(s):Healthy AdultsLast Updated:August 17, 2022Completed
Condition(s):Healthy Adult SubjectsLast Updated:August 30, 2022Completed
Condition(s):Prematurity; Vascular AgingLast Updated:November 18, 2023Recruiting
Condition(s):Clostridium Difficile DiarrheaLast Updated:October 19, 2020Terminated
Condition(s):Infant, Very Low Birth WeightLast Updated:February 18, 2010Completed
Condition(s):Infant, Very Low Birth WeightLast Updated:September 17, 2021Completed
Condition(s):Growth DelayLast Updated:January 18, 2020Unknown status
Condition(s):Bone Marrow Transplant – Autologous or AllogeneicLast Updated:August 20, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.